ORDER A TEST Log In Contact Us

TEMPUS STUDIES

Accelerate your clinical trials by leveraging our end to end solutions

We partner with forward-thinking life science companies to sponsor studies of their drugs, devices, and diagnostics, integrating our life science solutions to help achieve their objectives.

Our Solutions

  1. Multi-modal database

    Our extensive multimodal database and computational biology expertise enable rapid and data-driven protocol design.
  2. Next generation sequencing and validated AI algorithms

    Our scaled clinical sequencing lab and AI-driven algorithms enable you to pre-screen patients for biomarkers of interest and identify potentially eligible patients for studies.
  3. Extensive clinical trial network

    Our TIME network enables you to identify potential patients, quickly activate sites, and hit enrollment targets.
  4. CDx capabilities

    Our regulatory submission expertise and clinical trial sequencing experience naturally lends itself to downstream CDx development upon study readout.

Our Differentiators

  • ~7M

    de-identified multimodal records

  • 90+

    sites representing 500+ clinical locations

  • CDx development

    collaborations with several life science partners

  • Industry-leading regulatory expertise

    Tempus can submit and maintain the investigational new drug application (IND) for drug development studies

image description

Collaboration Timeline

Our end to end approach has been used to accelerate clinical trial start-up and execution for the PAVO study.

Read more about a Tempus-sponsored interventional study
  • 5 months from study hypothesis to IND submission and IRB approval
  • 60 days from IRB approval to first site activated, leveraging our TIME Trial Program, a just-in-time network of providers
  • 10 days from first site activated to first patient dosed
image description

Leverage our precision medicine infrastructure to accelerate clinical development using an innovative data-driven approach from study concept to registrational filing.

CONTACT TEMPUS